Taiko Pharmaceutical Co.,Ltd. (TYO:4574)

Taiko Pharmaceutical Revenue

Taiko Pharmaceutical had revenue of 1.15B JPY in the quarter ending March 31, 2025, a decrease of -16.49%. This brings the company's revenue in the last twelve months to 6.07B, down -4.19% year-over-year. In the year 2024, Taiko Pharmaceutical had annual revenue of 6.29B with 2.81% growth.

• Revenue (ttm): 6.07B
• Revenue Growth: -4.19%
• P/S Ratio: 2.36
• Revenue / Employee: 28.34M
• Employees: 214
• Market Cap: 14.31B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	6.29B	172.00M	2.81%
Dec 31, 2023	6.12B	1.08B	21.43%
Dec 31, 2022	5.04B	-6.26B	-55.39%
Dec 31, 2021	11.30B	-11.16B	-49.68%
Dec 31, 2020	22.46B	7.49B	50.05%